Drugs / Iso-Lyte
last change Oct 2019 re-read 2 minutes ago

Iso-Lyte

Developed for
infectious disease with sepsis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03366220 Comparator Mar 2018 → Sep 2019 infectious disease with sepsis The University of Texas Health Science Center, Houston Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Iso-Lyte “Usual care using balanced crystalloids (Iso-Lyte or Plasma-Lyte) only will follow Surviving Sepsis Campaign guidelines.” NCT03366220